Chapter 1 Methodology and Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Sample size for the study on North America Life Science Tools market:
1.3.1.1 Primary Sources
1.3.1.1.1 Details of Primary Research
1.3.1.2 Secondary Data Sources
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Market Model
1.6.1 Nucleic Acid Preparation market
1.6.2 Cell biology market
1.6.2.1 Comparison of 3D cell culture techniques
1.6.3 Next-Generation Sequencing & Transfection Electroporation market
1.6.4 Market study, by Technology
1.6.5 QFD modeling for market share assessment of technologies
1.6.6 Market study, by end use
1.7 Global Market: CAGR Calculation
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Summary, 2019
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market driver analysis
3.1.1.1 Increased government funding for life science technologies
3.1.1.2 Growth of cell and gene therapies
3.1.1.3 Rise in demand for biopharmaceuticals (biologics and biosimilars)
3.1.1.4 Technological advancements in life science tools
3.1.1.5 Applications of genomic and proteomic technologies for precision medicine
3.1.2 Market restraint analysis
3.1.2.1 High cost for some technologies
3.1.2.2 Dearth of skilled professionals
3.1.3 Market opportunity analysis
3.1.3.1 Rise in the number of strategic deals & developments
3.2 Penetration and Growth Prospect Mapping for Technology, 2019 (USD Million)
3.3 Impact of COVID-19 pandemic on North America Life Science Tools Market
3.3.1 Impact on the supply chain
3.3.2 Impact on life sciences & healthcare industry
3.4 Market Share Analysis
3.4.1 Company Size
3.4.2 Product portfolio
3.4.3 Strategic Initiatives
3.5 Business Environment Analysis
3.5.1 SWOT Analysis; By factor (Political & Legal, Economic, and Technological)
3.5.2 Porter’s Five Forces Analysis
Chapter 4 Technology Movement Analysis
4.1 Market: Technology Movement Analysis
4.2 Genomic Technology
4.2.1 Market estimates and forecast, 2016-2027 (USD Million)
4.3 Proteomics Technology
4.3.1 Market estimates and forecast, 2016-2027 (USD Million)
4.4 Cell Biology Technology
4.4.1 Market estimates and forecast, 2016-2027 (USD Million)
4.5 Other Analytical & Sample Preparation Technology
4.5.1 Market estimates and forecast, 2016-2027 (USD Million)
4.6 Lab Supplies & Technologies
4.6.1 Market estimates and forecast, 2016-2027 (USD Million)
Chapter 5 Product Business Analysis
5.1 North America Life Science Tools Market: Product Movement Analysis
5.2 Next-Generation Sequencing
5.2.1 Market estimates and forecast for NGS, 2016-2027 (USD Million)
5.2.2 Instruments
5.2.3 Consumables
5.2.4 Services
5.3 PCR & qPCR
5.3.1 Market estimates and forecast for PCR & qPCR, 2016-2027 (USD Million)
5.3.2 Instruments
5.3.3 Consumables
5.3.4 Services
5.4 Flow Cytometry
5.4.1 Market for flow cytometry, 2016-2027 (USD Million)
5.4.2 Instruments
5.4.3 Consumables
5.4.4 Services
5.5 Nuclear Magnetic Resonance Spectroscopy (NMR)
5.5.1 Market for Nuclear magnetic resonance spectroscopy, 2016-2027 (USD Million)
5.5.2 Instruments
5.5.3 Consumables
5.5.4 Services
5.6 Microscopy & Electron Microscopy
5.6.1 Market for microscopy & electron microscopy, 2016-2027 (USD Million)
5.6.2 Instruments
5.6.3 Consumables
5.6.4 Services
5.7 Liquid Chromatography (LC)
5.7.1 Market for liquid chromatography, 2016-2027 (USD Million)
5.7.2 Instruments
5.7.3 Consumables
5.7.4 Services
5.8 Mass Spectrometry (MS)
5.8.1 Market for mass spectrometry, 2016-2027 (USD Million)
5.8.2 Instruments
5.8.3 Consumables
5.8.4 Services
5.9 Nucleic Acid Preparation (NAP)
5.9.1 Market for nucleic acid preparation, 2016-2027 (USD Million)
5.9.2 Instruments
5.9.3 Consumables
5.9.4 Services
5.10 Transfection Electroporation
5.10.1 Market for transfection electroporation, 2016-2027 (USD Million)
5.10.2 Equipment
5.10.3 Reagents
5.11 Cell Biology
5.11.1 Market for cell biology, 2016-2027 (USD Million)
5.11.2 Instruments
5.11.2.1 Glassware
5.11.2.2 Culture ware
5.11.2.3 Others
5.11.3 Consumables
5.11.3.1 Media & sera
5.11.3.2 Reagents
5.11.4 Cell & tissue culture services
5.12 Cloning
5.12.1 Market for cloning, 2016-2027 (USD Million)
5.12.2 Kits, reagents, and consumables
5.12.3 Services
5.13 Other products & services
5.13.1 Market for other products & services, 2016-2027 (USD Million)
5.13.2 Antibodies
5.13.3 General supplies
5.13.4 Nucleic Acid Microarray
5.13.4.1 Instruments
5.13.4.2 Consumables
5.13.4.3 Services
5.13.5 Others
5.13.5.1 Market for others, 2016-2027 (USD Million)
5.13.5.2 Instruments
5.13.5.3 Consumables
5.13.5.4 Services
Chapter 6 End-use Movement Analysis
6.1 Market: End-use Movement Analysis
6.2 Government & Academic
6.2.1 Market for government & academic end use, 2016-2027 (USD Million)
6.3 Biopharmaceutical Company
6.3.1 Market for biopharmaceutical companies, 2016-2027 (USD Million)
6.4 Healthcare
6.4.1 Market for health care end use, 2016-2027 (USD Million)
6.5 Industrial Application
6.5.1 Market for industrial application, 2016-2027 (USD Million)
6.6 Others
6.6.1 Market for others end use, 2016-2027 (USD Million)
Chapter 7 Regional Movement Analysis
7.1 Market: Regional Movement Analysis
7.2 U.S.
7.2.1 Market estimates and forecast, by technology, 2016-2027 (USD Million)
7.2.2 Market estimates and forecast, by product, 2016-2027 (USD Million)
7.2.3 Market estimates and forecast, by end-use, 2016-2027 (USD Million)
7.3 Canada
7.3.1 Market estimates and forecast, by technology, 2016-2027 (USD Million)
7.3.2 Market estimates and forecast, by product, 2016-2027 (USD Million)
7.3.3 Market estimates and forecast, by end-use, 2016-2027 (USD Million)
Chapter 8 Company Profile
8.1 Company Profiles
8.1.1 Thermo Fisher Scientific, Inc.
8.1.1.1 Company Overview
8.1.1.1.1 Life Technologies Corp
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 F. Hoffmann-La Roche Ltd.
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 Illumina, Inc.
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Agilent Technologies
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 Becton, Dickinson and Company (BD)
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Bio-Rad Laboratories, Inc.
8.1.6.1 Company Overview
8.1.6.1.1 GnuBio
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic Initiatives
8.1.7 Danaher Corporation
8.1.7.1 Company Overview
8.1.7.1.1 Beckman Coulter, Inc.
8.1.7.1.2 Pall Corporation
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 General Electric Company
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Product Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 Merck KGaA
8.1.9.1 Company Overview
8.1.9.1.1 Sigma-Aldrich Co. LLC
8.1.9.1.2 Merck Millipore
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 QIAGEN
8.1.10.1 Company Overview
8.1.10.1.1 Ingenuity
8.1.10.1.2 CLC Bio
8.1.10.1.3 Exiqon
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking
8.1.10.4 Strategic Initiatives
8.1.11 Corning Incorporated
8.1.11.1 Company Overview
8.1.11.2 Financial Performance
8.1.11.3 Product Benchmarking
8.1.11.4 Strategic Initiatives
8.1.12 Perkin Elmer, Inc.
8.1.12.1 Company Overview
8.1.12.2 Financial Performance
8.1.12.3 Product Benchmarking
8.1.12.4 Strategic Initiatives
8.1.13 Miltenyi Biotec
8.1.13.1 Company Overview
8.1.13.2 Financial Performance
8.1.13.3 Product Benchmarking
8.1.13.4 Strategic Initiatives
8.1.14 Bruker
8.1.14.1 Company Overview
8.1.14.2 Financial Performance
8.1.14.3 Product Benchmarking
8.1.14.4 Strategic Initiatives
8.1.15 Hitachi Koki Co., Ltd.
8.1.15.1 Company Overview
8.1.15.2 Financial Performance
8.1.15.3 Product Benchmarking
8.1.15.4 Strategic Initiatives
8.1.16 Shimadzu Corporation
8.1.16.1 Company Overview
8.1.16.2 Financial Performance
8.1.16.3 Product Benchmarking
8.1.16.4 Strategic Initiatives
8.1.17 Oxford Instruments
8.1.17.1 Company Overview
8.1.17.2 Financial Performance
8.1.17.3 Product Benchmarking
8.1.17.4 Strategic Initiatives
List of Tables
Table 1 NIH common fund awards for biomedical research
Table 2 Business grants for life science and biotech in Canada
Table 3 Top biologic drugs in the U.S.
Table 4 List of molecular tests for COVID-19 diagnosis
Table 5 List of antigen diagnostic tests for COVID-19 diagnosis
Table 6 List of home-based molecular tests for COVID-19 diagnosis
Table 7 Illumina workflows to address COVID-19
Table 8 Danaher Corporation: Subsidiaries & functional areas
Table 9 Proteomic techniques: Advantages and disadvantages
Table 10 NGS instruments: Comparison
Table 11 Key vendors and models for mass spectrometry instruments
Table 12 Manufacturers & suppliers operating in the U.S.: Laboratory glassware
Table 13 Cloning related service providers in the U.S.
Table 14 Protein lysis buffers for different protein locations
Table 15 Total protein extraction reagents for laboratory use
Table 16 Applications of proteomics in the food and nutrition industry
Table 17 U.S. life science tools market estimates & forecasts, by technology, 2016-2027 (USD Million)
Table 18 U.S. life science tools market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 19 U.S. next-generation sequencing market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 20 U.S. PCR & qPCR market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 21 U.S. flow cytometry market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 22 U.S. NMR market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 23 U.S microscopy & electron microscopy market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 24 U.S. liquid chromatography market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 25 U.S. mass spectrometry market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 26 U.S. nucleic acid preparation market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 27 U.S. transfection electroporation market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 28 U.S. cell biology market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 29 U.S. cell biology instruments market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 30 U.S. cell biology consumables market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 31 U.S. cloning market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 32 U.S. other products & services market estimates & forecasts, by end-use, 2016-2027 (USD Million)
Table 33 U.S. nucleic acid microarray market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 34 U.S. other products market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 35 U.S. life science tools market estimates & forecasts, by end-use, 2016-2027 (USD Million)
Table 36 Canada life science tools market estimates & forecasts, by technology, 2016-2027 (USD Million)
Table 37 Canada life science tools market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 38 Canada next-generation sequencing market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 39 Canada PCR & qPCR market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 40 Canada flow cytometry market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 41 Canada NMR market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 42 U.S microscopy & electron microscopy market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 43 Canada liquid chromatography market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 44 Canada mass spectrometry market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 45 Canada nucleic acid preparation market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 46 Canada transfection electroporation market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 47 Canada cell biology market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 48 Canada cell biology instruments market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 49 Canada cell biology consumables market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 50 Canada cloning market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 51 Canada other products & services market estimates & forecasts, by end-use, 2016-2027 (USD Million)
Table 52 Canada nucleic acid microarray market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 53 Canada other products market estimates & forecasts, by product, 2016-2027 (USD Million)
Table 54 Canada life science tools market estimates & forecasts, by end-use, 2016-2027 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Executives contacted
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Analysis of individual techniques for global market modeling
Fig. 10 Ancillary market analysis
Fig. 11 Genetic analysis techniques market share analysis
Fig. 12 Commodity flow analysis modeling for nucleic acid preparation market
Fig. 13 Key products
Fig. 14 Comparison of 3D cell culture techniques
Fig. 15 Technology offerings of key players in the 3D cell culture market
Fig. 16 Next-generation sequencing market: Penetration of key players
Fig. 17 Transfection electroporation market: Penetration of key players
Fig. 18 QFD modeling for market share assessment of technologies
Fig. 19 Commodity flow analysis modeling for end-users
Fig. 20 End-use specific revenues generated by Agilent Technologies
Fig. 21 Penetration of key players in the academic/government end-use segment
Fig. 22 North America life science tools market snapshot, 2019 (USD Million)
Fig. 23 Market driver impact
Fig. 24 Cell therapies under investigation, by country
Fig. 25 Cell therapies under investigation, by type
Fig. 26 Clinical trials conducted for gene therapy
Fig. 27 Growth in net drug spending in the U.S. for biologics (USD Billion)
Fig. 28 Market restraint impact
Fig. 29 Penetration and growth prospect mapping
Fig. 30 Key macroeconomic challenges associated with the pandemic
Fig. 31 Key elements to enhance the supply chain post-COVID
Fig. 32 Total number of COVID-19 cases, by U.S. state
Fig. 33 Total number of deaths due to COVID-19, by U.S. state
Fig. 34 Number of COVID-19 tests performed, by U.S. state
Fig. 35 Types of COVID-19 tests
Fig. 36 Role of NGS to combat COVID-19 outbreak
Fig. 37 North America life science tools market share, by company, 2019 (%)
Fig. 38 SWOT Analysis, By Factor (Political & legal, economic, and technological)
Fig. 39 Porter’s Five Forces Analysis
Fig. 40 North America life science tools market: Technology outlook and key takeaways
Fig. 41 North America life science tools market: Technology movement analysis
Fig. 42 North America genomics technology market estimates and forecast, 2016-2027 (USD Million)
Fig. 43 North America proteomics technology market estimates and forecast, 2016-2027 (USD Million)
Fig. 44 North America cell biology technology market estimates and forecast, 2016-2027 (USD Million)
Fig. 45 North America other analytical & sample preparation technology market estimates and forecast, 2016-2027 (USD Million)
Fig. 46 North America lab supplies & technology market estimates and forecast, 2016-2027 (USD Million)
Fig. 47 North America life science tools market: Product movement analysis
Fig. 48 North America life science tools market estimates and forecast for NGS, 2016-2027 (USD Million)
Fig. 49 North America life science tools market estimates and forecast for NGS, by product 2016-2027 (USD Million)
Fig. 50 North America life science tools market estimates and forecast for PCR & qPCR, 2016-2027 (USD Million)
Fig. 51 North America life science tools market estimates and forecast for PCR & qPCR, by product 2016-2027 (USD Million)
Fig. 52 North America life science tools market for flow cytometry, 2016-2027 (USD Million)
Fig. 53 North America life science tools market estimates and forecast for flow cytometry, by product 2016-2027 (USD Million)
Fig. 54 North America life science tools market for nuclear magnetic resonance spectroscopy, 2016-2027 (USD Million)
Fig. 55 North America life science tools market estimates and forecast for NMR, by product 2016-2027 (USD Million)
Fig. 56 North America life science tools market for microscopy & electron microscopy, 2016-2027 (USD Million)
Fig. 57 North America life science tools market estimates and forecast for microscopy & electron microscopy, by product 2016-2027 (USD Million)
Fig. 58 North America life science tools market for liquid chromatography, 2016-2027 (USD Million)
Fig. 59 North America life science tools market estimates and forecast for LC, by product, 2016-2027 (USD Million)
Fig. 60 North America life science tools market for mass spectrometry, 2016-2027 (USD Million)
Fig. 61 North America life science tools market estimates and forecast for MS, by product 2016-2027 (USD Million)
Fig. 62 North America life science tools market for nucleic acid preparation, 2016-2027 (USD Million)
Fig. 63 North America life science tools market estimates and forecast for NAP, by product 2016-2027 (USD Million)
Fig. 64 North America life science tools market for transfection electroporation, 2016-2027 (USD Million)
Fig. 65 North America life science tools market estimates and forecast for transfection electroporation, by product 2016-2027 (USD Million)
Fig. 66 North America life science tools market for cell biology, 2016-2027 (USD Million)
Fig. 67 North America life science tools market estimates and forecast for cell biology, by product 2016-2027 (USD Million)
Fig. 68 North America life science tools market for cloning, 2016-2027 (USD Million)
Fig. 69 North America life science tools market estimates and forecast for cloning, by product 2016-2027 (USD Million)
Fig. 70 Cloning kits, reagents, and consumables offered by Merck
Fig. 71 North America life science tools market for other products & services, 2016-2027 (USD Million)
Fig. 72 North America life science tools market estimates and forecast for other products & services, by product 2016-2027 (USD Million)
Fig. 73 North America life science tools market for nucleic acid microarray, by product, 2016-2027 (USD Million)
Fig. 74 North America life science tools market for others, by product, 2016-2027 (USD Million)
Fig. 75 North America life science tools market: End-use outlook and key takeaways
Fig. 76 North America life science tools market: End-use movement analysis
Fig. 77 North America life science tools market for government & academic end use, 2016-2027 (USD Million)
Fig. 78 North America life science tools market for biopharmaceutical companies, 2016-2027 (USD Million)
Fig. 79 North America life science tools market for healthcare end use, 2016-2027 (USD Million)
Fig. 80 North America life science tools market for industry end use, 2016-2027 (USD Million)
Fig. 81 North America life science tools market for other end use, 2016-2027 (USD Million)
Fig. 82 North America life science tools market: Regional outlook and key takeaways
Fig. 83 North America life science tools market: Regional movement analysis
Fig. 84 U.S.
Fig. 85 U.S. life science tools market estimates and forecast, 2016-2027 (USD Million)
Fig. 86 Canada
Fig. 87 Canada life science tools market estimates and forecast, 2016-2027 (USD Million)
